Molecular Genetics of Follicular-Derived Thyroid Cancer

被引:35
|
作者
Macerola, Elisabetta [1 ]
Poma, Anello Marcello [1 ]
Vignali, Paola [1 ]
Basolo, Alessio [2 ]
Ugolini, Clara [1 ]
Torregrossa, Liborio [1 ]
Santini, Ferruccio [2 ]
Basolo, Fulvio [1 ]
机构
[1] Univ Pisa, Dept Surg Med Mol Pathol & Crit Area, Via Savi 10, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Clin & Expt Med, Via Savi 10, I-56126 Pisa, Italy
关键词
molecular genetics; molecular pathology; thyroid cancer; papillary thyroid cancer; TERT PROMOTER MUTATIONS; NUCLEAR FEATURES NIFTP; BRAF; TUMORS; LAROTRECTINIB; PATHOGENESIS; ASSOCIATION; MANAGEMENT; INHIBITORS; LANDSCAPE;
D O I
10.3390/cancers13051139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Thyroid tumors that derive from follicular cells are not a homogeneous entity, showing variable morphological appearance and different degrees of differentiation. Molecular markers are useful for both diagnostic purposes and prognostic stratification of patients. In presurgical setting, molecular testing of indeterminate thyroid nodules on aspirates provides useful diagnostic information; the molecular analysis on tumor tissues can also reveal the presence of genetic alterations related to patients' prognosis. In recent years, the molecular characterization of these tumors has acquired even more importance thanks to the introduction of targeted drugs. This review summarizes the current literature on the molecular landscape of follicular-derived thyroid tumors. Thyroid cancer is the most common type of endocrine-related malignancy, whose incidence rates have increased dramatically in the last few decades. Neoplasms of follicular origin generally have excellent prognosis, with the exception of less differentiated tumors. Follicular-derived thyroid cancer can manifest as a variety of morphologically distinct entities, characterized by various degrees of differentiation and invasiveness. Histological evaluation is thus crucial for the definition of patients' prognosis. However, within each histological subtype, tumor behavior can be highly variable, and, in this respect, molecular characterization can provide insightful information to refine the risk stratification of tumors. In addition to the importance of its prognostic role, molecular testing can be used to support the differential diagnosis of thyroid nodules in the absence of marked cyto-morphological aberrations. Finally, with the advent of targeted drugs, the presence of molecular alterations will guide the therapeutic strategies for patients with advanced tumors who do not respond to standard treatment. This review aims to describe the genetic landscape of follicular-derived thyroid tumors also highlighting differences across histological subtypes.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Indications for radioiodine administration in follicular-derived thyroid cancer
    Buffet, C.
    Ghander, C.
    le Marois, E.
    Leenhardt, L.
    ANNALES D ENDOCRINOLOGIE, 2015, 76 : 1S2 - 1S7
  • [2] Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
    Turner, Naimah
    Hamidi, Sarah
    Ouni, Rim
    Rico, Rene
    Henderson, Ying C.
    Puche, Maria
    Alekseev, Sayan
    Colunga-Minutti, Jocelynn G.
    Zafereo, Mark E.
    Lai, Stephen Y.
    Kim, Sang T.
    Cabanillas, Maria E.
    Nurieva, Roza
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] Cytologic features of aggressive variants of follicular-derived thyroid carcinoma
    Rossi, Esther Diana
    Faquin, William C.
    Pantanowitz, Liron
    CANCER CYTOPATHOLOGY, 2019, 127 (07) : 432 - 446
  • [4] ACTUALITIES IN GENETICS OF DIFFERENTIATED THYROID CANCER
    Dobrescu, R.
    Badiu, C.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2020, 16 (01) : 118 - 120
  • [5] Molecular genetics of thyroid cancer
    Rebai, Maha
    Rebai, Ahmed
    GENETICS RESEARCH, 2016, 98
  • [6] Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma
    Macerola, Elisabetta
    Proietti, Agnese
    Poma, Anello Marcello
    Vignali, Paola
    Sparavelli, Rebecca
    Ginori, Alessandro
    Basolo, Alessio
    Elisei, Rossella
    Santini, Ferruccio
    Basolo, Fulvio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [7] Analysis of RAS mutation and PAX8/PPARγ rearrangements in follicular-derived thyroid neoplasms in a Korean population: frequency and ultrasound findings
    Jeong, S. H.
    Hong, H. S.
    Kwak, J. J.
    Lee, E. H.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (08): : 849 - 857
  • [8] Clinical implications of molecular markers in follicular cell-derived thyroid cancer
    Pinto, Antonio E.
    Leite, Valeriano
    Soares, Jorge
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (07) : 679 - 694
  • [9] Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules
    Abd-El Raouf, Samar M.
    Ibrahim, Taiseer R.
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (12) : 971 - 978
  • [10] Follicular cell-derived thyroid cancer
    Dralle, Henning
    Machens, Andreas
    Basa, Johanna
    Fatourechi, Vahab
    Franceschi, Silvia
    Hay, Ian D.
    Nikiforov, Yuri E.
    Pacini, Furio
    Pasieka, Janice L.
    Sherman, Steven I.
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1